Quick Answer
Silence Therapeutics plc reported Net Income of -$88.61 million for fiscal year 2025.
Silence Therapeutics plc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$88.61M | -95.6% |
| 2024 | -$45.31M | +16.4% |
| 2023 | -$54.23M | -7.7% |
| 2022 | -$50.33M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$20.96M | +41.0% | +23.4% |
| June 30, 2025 | -$27.35M | -38.5% | +4.1% |
| March 31, 2025 | -$28.53M | -1134.0% | +19.7% |
| September 30, 2024 | -$35.54M | — | -79.9% |
| June 30, 2024 | -$19.75M | — | -754.5% |
| March 31, 2024 | -$2.31M | — | — |
- Silence Therapeutics plc showed a decrease of -95.6% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, Silence Therapeutics plc’s net income has declined by 76.0% (from -$50.33 million to -$88.61 million).
- The most recent figure is from Silence Therapeutics plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: